兴科蓉医药控股有限公司(06833)于2026年1月5日发布2025年12月的股份变动月报表。公告显示，截至2025年12月31日，公司已发行及注册股本维持不变，无新增股份发行、购回或注销活动。
根据公告，法定/注册股本维持在总额10,000,000,000股，面值每股港币0.0001，注册股本合计港币1,000,000。公司已发行普通股2,032,890,585股，与上个月底保持一致，库存股数量为零，无变动记录。
在股份期权及激励方面，公司于2025年5月26日采纳及生效的购股权计划未有新增授出、行使或失效的期权，相关数量仍为零。公告亦未披露任何其他发行或购回股份协议，说明公司12月股本结构整体稳定。
公告最后提及，公司确认当月所有有关证券事务均符合香港联交所《上市规则》及相关法律法规要求。该公告由董事会主席黄祥彬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.